In the News: The FDA in Action?
It’s a move that helps bring the FDA on board with the CDC, instead of simply reviewing and approving new pharmaceutical opioids for the marketplace.
Read MoreSelect Page
Posted by C. Scott McMillin | Apr 23, 2018 | In the News, Public Policy | 0 |
It’s a move that helps bring the FDA on board with the CDC, instead of simply reviewing and approving new pharmaceutical opioids for the marketplace.
Read MorePosted by C. Scott McMillin | Apr 19, 2018 | Prevention, Public Policy | 0 |
The theory is that the more users we put in jail or prison, the fewer left out on the street. So why hasn’t that substantially reduced arrest and overdose statistics?
Read MorePosted by C. Scott McMillin | Apr 16, 2018 | Addictive Substances | 1 |
They qualify for the diagnosis, but have not yet experienced the sort of problems that are usually required to motivate a serious attempt to abandon drug use.
Read MorePosted by C. Scott McMillin | Apr 12, 2018 | Thinking About Addiction | 0 |
Maybe you’ll even suggest the medication. And the marketing team wants you to leave the doctor’s office with a prescription for that med.
Read MorePosted by C. Scott McMillin | Apr 9, 2018 | Public Policy | 0 |
I’ve been expecting a public relations counterattack on behalf of, and probably funded by, the pharmaceutical industry.
Read More